Page last updated: 2024-09-05
tv3326 and xanthostigmine
tv3326 has been researched along with xanthostigmine in 1 studies
Compound Research Comparison
| Studies (tv3326) | Trials (tv3326) | Recent Studies (post-2010) (tv3326) | Studies (xanthostigmine) | Trials (xanthostigmine) | Recent Studies (post-2010) (xanthostigmine) |
|---|---|---|---|---|---|
| 15 | 0 | 11 | 9 | 0 | 2 |
Protein Interaction Comparison
| Protein | Taxonomy | tv3326 (IC50) | xanthostigmine (IC50) |
|---|---|---|---|
| Cholinesterase | Homo sapiens (human) | 0.0321 | |
| Acetylcholinesterase | Homo sapiens (human) | 0.0362 | |
| Adenosine receptor A1 | Bos taurus (cattle) | 0.0003 | |
| Acetylcholinesterase | Rattus norvegicus (Norway rat) | 0.0151 | |
| Carboxylic ester hydrolase | Rattus norvegicus (Norway rat) | 0.048 |
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Bolognesi, ML; Cavalli, A; Melchiorre, C; Minarini, A; Recanatini, M; Rosini, M; Tumiatti, V | 1 |
Reviews
1 review(s) available for tv3326 and xanthostigmine
| Article | Year |
|---|---|
Multi-target-directed ligands to combat neurodegenerative diseases.
Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Antioxidants; Binding Sites; Calcium Channel Blockers; Chelating Agents; Cholinesterase Inhibitors; Humans; Huntington Disease; Ligands; Multiple Sclerosis; Neurodegenerative Diseases; Neurofibrillary Tangles; Neurotransmitter Agents; Parkinson Disease; Plaque, Amyloid | 2008 |